---
figid: PMC6305103__ganc-09-155-g002
figtitle: Tumor metabolism regulating chemosensitivity in ovarian cancer
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6305103
filename: ganc-09-155-g002.jpg
figlink: /pmc/articles/PMC6305103/figure/F2/
number: F2
caption: Enhanced glycolysis in cancer cells, through a combination of metabolic pathways,
  drives glucose utilization to fulfill high anabolic demands. In this schematic diagram
  of the glycolysis pathway, metabolites are shown as square boxes. Key regulatory
  molecules which either promote (yellow box) or suppresses (purple box) glycolytic
  enzymes and metabolites such as G-6-P are shown. GLUT (glucose transporter), G-6-P
  (glucose-6-phosphate), F-6-P (fructose-6-phosphate), F-1,6-BP (fructose-1,6-bisphosphate),
  G-3-P( glyceraldehyde 3-phosphate), 1,3-BPG (1,3-bisphosphoglycerate), 2-PG (2-phosphoglycerate),
  3-PG (3-phophosphoglycerate); PEP (phosphoenolpyruvate), PFK (phosphofructokinase),
  GAPDH (glyceraldehyde 3-phosphate dehydrogenase), TIGAR (TP53-inducible glycolysis
  and apoptosis regulator), ENO (enolase), MCT (monocarboxylate transporter). mTORC1
  (mTOR complex 1), Mutant p53 (defect p53), PFKFB (6‑phosphofructo 2‑kinase/fructose‑2,6‑bisphosphatase),
  Akt (Protein Kinase B), HIF-1α (hypoxia Inducible Factor-1α), c-Myc (v-myc avian
  myelocytomatosis viral oncogene homolog), and LPA (Lysophosphatidic acid).
papertitle: Tumor metabolism regulating chemosensitivity in ovarian cancer.
reftext: Chae Young Han, et al. Genes Cancer. 2018 May;9(5-6):155-175.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9157161
figid_alias: PMC6305103__F2
figtype: Figure
redirect_from: /figures/PMC6305103__F2
ndex: 867bd577-df0e-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6305103__ganc-09-155-g002.html
  '@type': Dataset
  description: Enhanced glycolysis in cancer cells, through a combination of metabolic
    pathways, drives glucose utilization to fulfill high anabolic demands. In this
    schematic diagram of the glycolysis pathway, metabolites are shown as square boxes.
    Key regulatory molecules which either promote (yellow box) or suppresses (purple
    box) glycolytic enzymes and metabolites such as G-6-P are shown. GLUT (glucose
    transporter), G-6-P (glucose-6-phosphate), F-6-P (fructose-6-phosphate), F-1,6-BP
    (fructose-1,6-bisphosphate), G-3-P( glyceraldehyde 3-phosphate), 1,3-BPG (1,3-bisphosphoglycerate),
    2-PG (2-phosphoglycerate), 3-PG (3-phophosphoglycerate); PEP (phosphoenolpyruvate),
    PFK (phosphofructokinase), GAPDH (glyceraldehyde 3-phosphate dehydrogenase), TIGAR
    (TP53-inducible glycolysis and apoptosis regulator), ENO (enolase), MCT (monocarboxylate
    transporter). mTORC1 (mTOR complex 1), Mutant p53 (defect p53), PFKFB (6‑phosphofructo
    2‑kinase/fructose‑2,6‑bisphosphatase), Akt (Protein Kinase B), HIF-1α (hypoxia
    Inducible Factor-1α), c-Myc (v-myc avian myelocytomatosis viral oncogene homolog),
    and LPA (Lysophosphatidic acid).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - sima
  - p53
  - betaTub60D
  - hth
  - Glut1
  - Glut3
  - Akt
  - Myc
  - Crtc
  - G6P
  - Pten
  - Pfk
  - Ldh
  - Mct1
  - MCTS1
  - Gapdh2
  - Gpdh1
  - Gapdh1
  - pkm
  - PyK
  - pk
  - Eno
  - Pep
  - bgcn
  - Coa
  - CycE
  - cyc
  - KRAS
  - NRAS
  - BRAF
  - HIF1A
  - TP53
  - TP63
  - TP73
  - SLC2A1
  - SLC2A3
  - AKT1
  - AKT2
  - AKT3
  - MYC
  - LPA
  - MTOR
  - RPTOR
  - MIR155
  - HK1
  - HK3
  - PTEN
  - TIGAR
  - MIR143
  - PFKM
  - SLC16A4
  - SLC16A3
  - LDHA
  - LDHB
  - LDHC
  - CMA1
  - SLC16A1
  - MCAT
  - GAPDH
  - GAPDHP44
  - PKM
  - PKLR
  - ENO1
  - ENO2
  - ENO3
  - ENO4
  - PAEP
  - PREP
  - PTPN22
  - LPA
  - Glucose
  - F-6-P
  - Lactate
  - ENO
  - Pyruvate
  - TCA
  - Acetyl
  - Cancer
---
